PBH
NYSE · Pharmaceuticals
Prestige Consumer Healthcare
$42.98
-1.34 (-3.02%)
Performance
1D
+0.00%
1W
-13.57%
1M
-10.22%
3M
-18.91%
6M
-15.14%
1Y
-28.31%
YTD
-29.79%
Open$43.51
Previous Close$44.32
Day High$43.62
Day Low$41.77
52W High$71.07
52W Low$42.62
Volume—
Avg Volume664.0K
Market Cap2.06B
P/E Ratio11.98
EPS$3.57
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$48.16
Below
SMA 200
$53.64
Below
RSI (14)
35.2
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
10 analysts
Price Target
+81.8% upside
Current
$42.98
$42.98
Target
$78.15
$78.15
$50.25
$78.15 avg
$108.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.07B | 1.08B | 462.83M |
| Net Income | 187.20M | 170.47M | 138.88M |
| Profit Margin | 17.5% | 16.6% | 30.0% |
| EBITDA | 324.96M | 312.37M | 217.92M |
| Free Cash Flow | — | — | 109.94M |
| Rev Growth | -1.2% | -1.2% | +15.0% |
| Debt/Equity | 0.54 | 0.54 | 0.82 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |